AC IMMUNE SA SF-02 Cash Flow Quality Index

Latest as of September 2024: -2.57x

AC IMMUNE SA SF-02 cash flow quality index. AC IMMUNE SA SF-02 (IMR) has a Cash Flow Quality Index of -2.57x as of September 2024. Operating cash flow of €-14.14 Million is below net income of €5.50 Million, suggesting accrual-heavy earnings not yet converted to cash. See AC IMMUNE SA SF-02 leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-2.57x

Operating CF / Net Income

Operating Cash Flow

€-14.14 Million

EUR

Net Income

€5.50 Million

EUR

Data as of

Sep 2024

Most recent filing

AC IMMUNE SA SF-02 Cash Flow Quality Index by Year (None–None)

AC IMMUNE SA SF-02 cash flow quality index by year from None to None. Year-by-year earnings quality comparison for AC IMMUNE SA SF-02. For the full cash flow conversion analysis, see IMR operating cash flow.

Year	Quality Index	Operating CF (EUR)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.